Revvity (NYSE: RVTY)
Revvity Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Revvity Company Info
Revvity, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment consists of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.
News & Analysis
Why Revvity Stock Plunged Today
Revvity announced disappointing results and lowered its full-year outlook. Here's what investors need to know.
Why Shares of PerkinElmer Dropped 14.4% in January
The laboratory testing company saw its shares plummet nearly $40 per share over the course of the month.
3 Strong Stocks for Your Income Tax Return
A tax refund is a great opportunity to invest in these three medical companies that have solid revenue growth ahead.
How PerkinElmer Beat Expectations in Q4
The short answer: Increased demand for COVID-19 testing.
Why Is Nobody Talking About PerkinElmer Stock?
PerkinElmer's shares have risen more than 47% in 2020, so why isn't everyone talking about this fast-rising testing company?
The FDA Just Ranked Coronavirus Tests by Sensitivity. Here's What That Means
You know what they say! To the most sensitive tests go the spoils.
FDA Evaluates 5 More COVID-19 Antibody Tests
Independent analysis shows some of the post-exposure tests work fairly well.
What Investors Liked and Didn't Like About PerkinElmer's Q4 Earnings Results
The global healthcare company beat analysts' estimates in Q4 but disappointed with its 2020 Q1 outlook.
Valuation
Earnings Transcripts
PerkinElmer, Inc (PKI) Q3 2021 Earnings Call Transcript
PKI earnings call for the period ending October 30, 2021.
PerkinElmer, inc (PKI) Q2 2021 Earnings Call Transcript
PKI earnings call for the period ending June 30, 2021.
PerkinElmer Inc (PKI) Q1 2021 Earnings Call Transcript
PKI earnings call for the period ending March 31, 2021.
PerkinElmer Inc (PKI) Q4 2020 Earnings Call Transcript
PKI earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.